X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinicaltrialsarena.com/news/aum-first-patient-mss-crc/
https://www.globenewswire.com/news-release/2023/04/26/2655179/0/en/AUM-Biosciences-to-Participate-in-Inaugural-EF-Hutton-Global-Conference.html
https://www.globenewswire.com//news-release/2023/01/05/2583667/0/en/AUM-Biosciences-Receives-U-S-FDA-Rare-Pediatric-Disease-Designation-for-AUM302-for-Treatment-of-Neuroblastoma.html
https://www.globenewswire.com//news-release/2022/11/30/2564921/0/en/AUM-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-AUM302-for-the-Treatment-of-Neuroblastoma.html
https://www.globenewswire.com/news-release/2022/11/15/2556081/0/en/AUM-Biosciences-Receives-Human-Research-Ethics-Committee-Approval-to-Commence-Phase-II-Clinical-Trial-of-AUM001-for-Treatment-of-Metastatic-Colorectal-Cancer-in-Australia.html
https://www.globenewswire.com/news-release/2022/11/04/2548762/0/en/AUM-Biosciences-to-Participate-in-BioCentury-BayHelix-East-West-BioPharma-Summit.html
https://www.fiercebiotech.com/biotech/spac-fashion-cancer-focused-aum-latest-biotech-use-blank-check-route
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/aum-biosciences-merges-with-nasdaq-listed-mountain-crest/articleshow/94993518.cms
https://www.prnewswire.com/news-releases/aum-biosciences-and-asymchem-complete-phase-ii-api-production-campaign-of-novel-trk-inhibitor-301654430.html
https://www.globenewswire.com/news-release/2022/10/20/2538036/0/en/AUM-Biosciences-a-Global-Biotechnology-Company-Developing-Precision-Oncology-Therapeutics-Announces-Plans-to-Become-a-Public-Company-via-Merger-with-Mountain-Crest-Acquisition-Corp.html
Market Place
Share 
